Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Preveceutical Medical Inc. is currently managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct art units, which indicates that the company's intellectual property covers diverse technical aspects within the pharmaceutical sector. The involvement of 2 distinct examiners means that each pending application is being reviewed by a different individual at the patent office.
BARSKY, JARED is identified as the busiest examiner for this portfolio, with 1 pending office action under his review. With a total of 2 pending office actions and 2 distinct examiners, the workload is split among the assigned staff. This 1 pending office action represents the current focus of the busiest examiner. The spread across 2 distinct art units suggests that the prosecution team must be prepared to address the specific nuances and examination styles of different divisions within the patent office.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARSKY, JARED | 1 | 50.2% | +22.7% |
| BOWLES, DAVID PAUL | 1 | 72.7% | +22.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18043398 | CANNABINOID FORMULATIONS AND METHODS OF USE | BARSKY, JARED | 66d overdue |
| 17424649 | A CYCLIC PEPTIDE | BOWLES, DAVID PAUL | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18043398 | CANNABINOID FORMULATIONS AND METHODS OF USE | BARSKY, JARED | 1628 | §103 | Final Rejection | 66d overdue | Pending | Feb 28, 2023 |
| 17424649 | A CYCLIC PEPTIDE | BOWLES, DAVID PAUL | 1654 | §112 | Final Rejection | — | Pending | Jul 21, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial